Antidepressants Market Forecast: Industry Research Report

Antidepressants Market Forecast

Published Date: October 2009

Published By: Datamonitor

Page Count: 125

Order Code: R313-55060

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Introduction

With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial potential and the most promising candidate to date is Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine).

Reasons to Purchase

Quantify the current (2008) and future (2009-2018) size of the antidepressant drug class market.
Assess the impact of recent and anticipated events (patent expiries and new product launches) on the antidepressant drug class market.
Understand the country-specific impact of key events in the antidepressant drug class market during the forecast period 2009 to 2018.

Please note: this is delivered as a Zip file.

Similar Products

• Snapshots US Pharmaceuticals 2009

Published Nov 2009 by Snapdata International Group

• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

Published Nov 2009 by Aruvian's R'search

• Pharmaceutical Industry in Mexico

Published Nov 2009 by Aruvian's R'search

• Pharmaceuticals Industry Report

Published Nov 2009 by Plimsoll Publishing Ltd.

• Antipsychotics Market Forecast

Published Oct 2009 by Datamonitor